Skip to content

Study on the Anti-inflammatory Effect of Auricular Electroacupuncture on Ulcerative Colitis

Study on the Anti-inflammatory Effect of Auricular Electroacupuncture on Ulcerative Colitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040484
Enrollment
Unknown
Registered
2020-11-30
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

Control group:Routine treatment

Sponsors

Affiliated Wuxi 2nd People's Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of western medicine; 2. Meet the diagnostic criteria of Chinese medicine; 3. Mild to moderate patients who meet the modified Mayo score of 3-10; 4. Aged 18-70 years old; 5. The patient has not implanted other electronic devices for a long time; 6. No antibiotics or probiotics have been taken in the past month; 7. No history of diarrhea or other gastrointestinal diseases in the past 4 weeks; 8. No skin damage in the outer ear; 9. Patients who signed informed consent and cooperated with examination and treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with severe complications, such as local stenosis, intestinal obstruction, intestinal perforation, rectal polyps, toxic colonic dilatation, colon cancer, rectal cancer and anal diseases; 2. Women under the age of 18 or over 70, pregnant or preparing to become pregnant, and lactating women; 3. Patients with severe primary diseases such as liver and kidney, cardio-cerebrovascular or hematopoietic system, and mental illness; 4. People with allergies and allergies to multiple drugs; 5. The patient's condition aggravated midway, urgent measures must be taken, the curative effect could not be judged, or the information was incomplete, which affected the judgment of curative effect.

Design outcomes

Primary

MeasureTime frame
Tumor Necrosis Factor-alpha;Improved Mayo Score;

Secondary

MeasureTime frame
Interleukin-6;Interleukin-1;Intestinal flora;Intestinal flora;

Countries

China

Contacts

Public ContactShen Cuicui

Affiliated Wuxi 2nd People's Hospital of Nanjing Medical University

scc128@sina.com+86 15050687936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026